← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dormatarg, Inc.
Oklahoma City, OK
$2,652,719
Total funding
4
Grants
Funding over time
peak $1.2M · FY2008–12$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,652,719 · 4
By mechanism
R44$1,974,199 · 1
R43$678,520 · 3
Investigators at Dormatarg, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Drugs Targeting Dormant Tumors as Anti-Metastatic Agents$1,102,521
R44 · FY2011 · CA
Drugs Targeting Dormant Tumors as Anti-Metastatic Agents$871,678
R44 · FY2012 · CA
Identifying the drug target in dormant cancer cells$296,937
R43 · FY2012 · CA
Preventing bladder cancer recurrence and metastasis$259,133
R43 · FY2009 · CA
Drugs Targeting Dormant Tumors as Anti-Metastatic Agents$122,450
R43 · FY2008 · CA